954 — Changmao Biochemical Engineering Co Balance Sheet
0.000.00%
- HK$150.96m
- HK$642.23m
- CNY584.79m
Annual balance sheet for Changmao Biochemical Engineering Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 134 | 58.8 | 63.6 | 96.6 | 74.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 87.2 | 115 | 118 | 102 | 74.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 409 | 317 | 362 | 338 | 299 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 401 | 598 | 773 | 866 | 925 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 847 | 957 | 1,207 | 1,242 | 1,250 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 196 | 257 | 274 | 325 | 605 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 198 | 259 | 428 | 591 | 666 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 649 | 697 | 779 | 652 | 583 |
Total Liabilities & Shareholders' Equity | 847 | 957 | 1,207 | 1,242 | 1,250 |
Total Common Shares Outstanding |